Time to endovascular reperfusion and degree of disability in acute stroke.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 26153450)

Published in Ann Neurol on August 17, 2015

Authors

Sunil A Sheth1, Reza Jahan1, Jan Gralla2, Vitor M Pereira3, Raul G Nogueira4, Elad I Levy5, Osama O Zaidat6, Jeffrey L Saver7, SWIFT-STAR Trialists

Author Affiliations

1: Division of Interventional Neuroradiology and Stroke Center, University of California, Los Angeles, CA.
2: Department of Diagnostic and Interventional Neuroradiology, Inselspital, University of Bern, Bern, Switzerland.
3: Departments of Medical Imaging and Surgery, Toronto Western Hospital and University Health Network, University of Toronto, Toronto, Ontario, Canada.
4: Department of Neurology, Emory University, Atlanta, GA.
5: Departments of Neurosurgery and Radiology and Toshiba Stroke and Vascular Research Center, University at Buffalo, State University of New York.
6: Department of Neurology, Medical College of Wisconsin, Milwaukee, WI.
7: Department of Neurology and Stroke Center, University of California, Los Angeles, CA.

Articles cited by this

A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med (2014) 18.12

Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med (2015) 12.70

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet (2010) 12.21

Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med (2015) 12.06

Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med (2015) 9.58

Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet (2012) 8.76

Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet (2012) 7.89

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke (2003) 7.75

Time is brain--quantified. Stroke (2005) 6.96

Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score. Lancet (2000) 6.53

Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA (2013) 5.05

Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial. Lancet Neurol (2014) 3.61

Statistical analysis of the primary outcome in acute stroke trials. Stroke (2012) 3.52

Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology (2009) 3.45

A simple, assumption-free, and clinically interpretable approach for analysis of modified Rankin outcomes. Stroke (2012) 2.57

Number needed to treat to benefit and to harm for intravenous tissue plasminogen activator therapy in the 3- to 4.5-hour window: joint outcome table analysis of the ECASS 3 trial. Stroke (2009) 2.00

Prospective, multicenter, single-arm study of mechanical thrombectomy using Solitaire Flow Restoration in acute ischemic stroke. Stroke (2013) 1.94

Number needed to treat estimates incorporating effects over the entire range of clinical outcomes: novel derivation method and application to thrombolytic therapy for acute stroke. Arch Neurol (2004) 1.86

Treatment time-specific number needed to treat estimates for tissue plasminogen activator therapy in acute stroke based on shifts over the entire range of the modified Rankin Scale. Stroke (2009) 1.72

"Picture to puncture": a novel time metric to enhance outcomes in patients transferred for endovascular reperfusion in acute ischemic stroke. Circulation (2013) 1.47

Impact of onset-to-reperfusion time on stroke mortality: a collaborative pooled analysis. Circulation (2013) 1.41

A brief prehospital stroke severity scale identifies ischemic stroke patients harboring persisting large arterial occlusions. Stroke (2008) 1.24

Optimal end points for acute stroke therapy trials: best ways to measure treatment effects of drugs and devices. Stroke (2011) 1.21

Optimal workflow and process-based performance measures for endovascular therapy in acute ischemic stroke: analysis of the Solitaire FR thrombectomy for acute revascularization study. Stroke (2014) 1.20

Higher volume endovascular stroke centers have faster times to treatment, higher reperfusion rates and higher rates of good clinical outcomes. J Neurointerv Surg (2012) 1.09

Effect of time to reperfusion on clinical outcome of anterior circulation strokes treated with thrombectomy: pooled analysis of the MERCI and Multi MERCI trials. Stroke (2011) 1.01